Urologic Oncology: Seminars and Original Investigations
Volume 29, Issue 6 , Pages 690-697 , November 2011

Significance of focal proliferative atrophy lesions in prostate biopsy cores that test negative for prostate carcinoma

  • Anastasios D. Asimakopoulos, M.D.

      Affiliations

    • Division of Urology, Department of Surgery, Policlinico Tor Vergata, University of Tor Vergata, Rome, Italy
    • These authors contributed equally to this work.
    • Corresponding Author InformationCorresponding author. Tel.: +39-06-20902835; fax: +39-06-20902975
    • ,
  • Roberto Miano, M.D.

      Affiliations

    • Division of Urology, Department of Surgery, Policlinico Tor Vergata, University of Tor Vergata, Rome, Italy
    • These authors contributed equally to this work.
    • ,
  • Alessandro Mauriello, M.D.

      Affiliations

    • Institute of Pathology, University of Rome Tor Vergata, Rome, Italy
    • ,
  • Sara Costantini, M.D.

      Affiliations

    • Institute of Pathology, University of Rome Tor Vergata, Rome, Italy
    • ,
  • Patrizio Pasqualetti

      Affiliations

    • Medical Statistics and Information Technology, Fatebenefratelli Association for the Research, Isola Tiberina, Rome, Italy
    • Casa di Cura San Raffaele Cassino e Irccs San Raffaele Pisana, Rome, Italy
    • ,
  • Emanuele Liberati, M.D.

      Affiliations

    • Division of Urology, Department of Surgery, Policlinico Tor Vergata, University of Tor Vergata, Rome, Italy
    • ,
  • Enrico Finazzi Agrò, M.D.

      Affiliations

    • Division of Urology, Department of Surgery, Policlinico Tor Vergata, University of Tor Vergata, Rome, Italy
    • ,
  • Stefano Germani, M.D.

      Affiliations

    • Division of Urology, Department of Surgery, Policlinico Tor Vergata, University of Tor Vergata, Rome, Italy
    • ,
  • Guido Virgili, M.D.

      Affiliations

    • Division of Urology, Department of Surgery, Policlinico Tor Vergata, University of Tor Vergata, Rome, Italy
    • ,
  • Giuseppe Vespasiani, M.D.

      Affiliations

    • Division of Urology, Department of Surgery, Policlinico Tor Vergata, University of Tor Vergata, Rome, Italy

Received 4 September 2009 ,Revised 27 January 2010 ,Accepted 28 January 2010.

References 

  1. Ruska KM, Sauvageot J, Epstein JI. Histology and cellular kinetics of prostatic atrophy. Am J Surg Pathol. 1998;22:1073–1077
  2. De Marzo AM, Marchi VL, Epstein JI, et al. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis. Am J Pathol. 1999;155:1985–1992
  3. De Marzo AM, Platz EA, Epstein JI, et al. A Working group classification of focal prostate atrophy lesions. Am J Surg Pathol. 2006;30:1981–1991
  4. Billis A. Prostatic atrophy: An autopsy study of a histologic mimic of adenocarcinoma. Mod Pathol. 1998;11:47–54
  5. Tomas D, Kruslin B, Rogatsch H, et al. Different types of atrophy in the prostate with and without adenocarcinoma. Eur Urol. 2007;51:98–103
  6. Postma R, Schroder FH, van der Kwast TH. Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology. 2005;65:745–749
  7. Tsujimoto Y, Takayama H, Nonomura N, et al. Postatrophic hyperplasia of the prostate in Japan: Histologic and immunohistochemical features and p53 gene mutation analysis. Prostate. 2002;52:279–287
  8. Faith D, Han S, Lee DK, et al. P16 is up-regulated in proliferative inflammatory atrophy of the prostate. Prostate. 2005;65:73–82
  9. Uetsuki H, Tsunemori H, Taoka R, et al. Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate. J Urol. 2005;174:514–518
  10. Hager M, Mikuz G, Bartsch G, et al. The association between local atherosclerosis and prostate cancer. BJU Int. 2007;99:46–48
  11. Palapattu GS, Sutcliffe S, Bastian PJ, et al. Prostate carcinogenesis and inflammation: Emerging insights. Carcinogenesis. 2005;26:1170–1181
  12. Nelson GW, De Marzo A, Isaacs WB. Prostate cancer. N Engl J Med. 2003;349:366–381
  13. Putzi MJ, De Marzo AM. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology. 2000;56:828–832
  14. Billis A, Magna LA. Inflammatory atrophy of the prostate (Prevalence and significance). Arch Pathol Lab Med. 2003;127:840–844
  15. Anton RC, Kattan MW, Chakraborty S, et al. Postatrophic hyperplasia of the prostate: Lack of association with prostate cancer. Am J Surg Pathol. 1999;23:932–936
  16. Billis A, Freitas LL, Magna LA, et al. Inflammatory atrophy on prostate needle biopsies: Is there topographic relationship to cancer?. Int Braz J Urol. 2007;33:355–360
  17. Egevad L. Editorial comment. Eur Urol. 2007;51:103–104
  18. Franks LM. Atrophy and hyperplasia in the prostate proper. J Pathol Bacteriol. 1954;68:617–621
  19. Herawi M, Parwani AV, Irie J, et al. Small glandular proliferations on needle biopsies: Most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion. Am J Surg Pathol. 2005;29:874–880
  20. Montironi R, Mazzucchelli R, Lopez-Beltran A, et al. Mechanisms of disease: High-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Nat Clin Pract Urol. 2007;4:321–332
  21. Borowsky AD, Dingley KH, Ubick E, et al. Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model. Neoplasia. 2006;8:708–715
  22. De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007;74:256–269
  23. Nakayama M, Bennett CJ, Hicks JL, et al. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: A detailed study using laser-capture microdissection. Am J Pathol. 2003;163:923–933
  24. Wang W, Bergh A, Damber JE. Chronic inflammation in benign prostatic hyperplasia is associated with focal up-regulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium. Prostate. 2004;61:60–72
  25. Macoska JA, Trybus TM, Wojno KJ. 8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancer. Urology. 2000;55:776–782
  26. Woenckhaus J, Fenic I. Proliferative inflammatory atrophy: A background lesion of prostate cancer?. Andrologia. 2008;40:134–137
  27. Billis A, Meirelles LR, Magna LA, et al. Extent of prostatic atrophy in needle biopsies and serum PSA levels: Is there an association?. Urology. 2007;69:927–930
  28. Kandirali E, Boran C, Serin E, et al. Association of extent and aggressiveness of inflammation with serum PSA levels and PSA density in asymptomatic patients. Urology. 2007;70:743–747
  29. Morote Robles J, López M, Encabo Duro G, et al. The incidence of lesions associated with prostatic biopsy and its effect on the serum concentration of the prostate-specific antigen. Actas Urol Esp. 1999;23:400–405
  30. Chang SG, Kim CS, Jeon SH, et al. Is chronic inflammatory change in the prostate the major cause of rising serum prostate-specific antigen in patients with clinical suspicion of prostate cancer?. Int J Urol. 2006;13:122–126
  31. Brand TC, Thibault GP, Basler JW. Dealing with non-cancerous findings on prostate biopsy. Curr Urol Rep. 2006;7:186–192

PII: S1078-1439(10)00038-4

doi: 10.1016/j.urolonc.2010.01.010

Urologic Oncology: Seminars and Original Investigations
Volume 29, Issue 6 , Pages 690-697 , November 2011

Article Tools

* Image Usage & Resolution